secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072531
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Joel Jung as Interim CFO with $8k/month salary and 60k options
-----------------------------------------------------------------------

- Interim CFO Joel Jung receives $8,000 monthly base salary under consulting agreement.
- Option grant of 60,000 ordinary shares; 1/4 vest Aug 28, 2024, rest monthly over 9 months.
- Exercise price equals closing price of ordinary shares on AIM on day before grant.
- Options fully vest upon change in control; agreement terminable with 3 months' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024072531/0000950170-24-072531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024072531/rnlx-20240607.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer